About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Npj Parkinson's Disease
›
top-articles
Npj Parkinson's Disease
7.5
(top 2%)
impact factor
535
(top 50%)
papers
10.8K
(top 20%)
citations
49
(top 10%)
h
-index
7.8
(top 2%)
impact factor
741
all documents
13.1K
doc citations
79
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Prevalence of Parkinson’s disease across North America
Npj Parkinson's Disease
2018
611
2
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Npj Parkinson's Disease
2017
388
3
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Npj Parkinson's Disease
2021
315
4
Current and projected future economic burden of Parkinson’s disease in the U.S.
Npj Parkinson's Disease
2020
265
5
Modeling Parkinson’s disease in midbrain-like organoids
Npj Parkinson's Disease
2019
204
6
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease
Npj Parkinson's Disease
2017
189
7
LRRK2 levels in immune cells are increased in Parkinson’s disease
Npj Parkinson's Disease
2017
177
8
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
Npj Parkinson's Disease
2018
169
9
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
Npj Parkinson's Disease
2016
143
10
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Npj Parkinson's Disease
2020
140
11
Parkinson’s disease: proteinopathy or lipidopathy?
Npj Parkinson's Disease
2020
138
12
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
Npj Parkinson's Disease
2020
120
13
Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health
Npj Parkinson's Disease
2018
110
14
Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control study
Npj Parkinson's Disease
2015
108
15
Parkinson’s disease as a system-level disorder
Npj Parkinson's Disease
2016
108
16
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
Npj Parkinson's Disease
2018
108
17
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease
Npj Parkinson's Disease
2018
101
18
The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence
Npj Parkinson's Disease
2017
99
19
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
Npj Parkinson's Disease
2017
98
20
Cognitive decline in Parkinson’s disease: the complex picture
Npj Parkinson's Disease
2016
96
21
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
Npj Parkinson's Disease
2019
95
22
Integrated molecular landscape of Parkinson’s disease
Npj Parkinson's Disease
2017
92
23
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Npj Parkinson's Disease
2018
92
24
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Npj Parkinson's Disease
2020
90
25
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
Npj Parkinson's Disease
2019
86
26
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
Npj Parkinson's Disease
2019
83
27
Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
Npj Parkinson's Disease
2020
81
28
Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson’s disease: a task-based fMRI study
Npj Parkinson's Disease
2015
75
29
Creation of a library of induced pluripotent stem cells from Parkinsonian patients
Npj Parkinson's Disease
2016
74
30
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Npj Parkinson's Disease
2021
74
31
Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models
Npj Parkinson's Disease
2015
73
32
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
Npj Parkinson's Disease
2018
70
33
Sex specific cognitive differences in Parkinson disease
Npj Parkinson's Disease
2020
69
34
The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review
Npj Parkinson's Disease
2015
67
35
Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
Npj Parkinson's Disease
2018
66
36
Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life
Npj Parkinson's Disease
2020
65
37
Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease
Npj Parkinson's Disease
2017
63
38
Parkinson’s progression prediction using machine learning and serum cytokines
Npj Parkinson's Disease
2019
63
39
The use of accelerometry as a tool to measure disturbed nocturnal sleep in Parkinson’s disease
Npj Parkinson's Disease
2018
62
40
Fatigue in Parkinson’s disease: report from a multidisciplinary symposium
Npj Parkinson's Disease
2016
61
41
Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
Npj Parkinson's Disease
2018
61
42
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
Npj Parkinson's Disease
2018
61
43
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease
Npj Parkinson's Disease
2017
60
44
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease
Npj Parkinson's Disease
2019
60
45
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
Npj Parkinson's Disease
2018
59
46
Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation
Npj Parkinson's Disease
2019
58
47
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
Npj Parkinson's Disease
2021
58
48
Dynamic control of the dopamine transporter in neurotransmission and homeostasis
Npj Parkinson's Disease
2021
58
49
Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room
Npj Parkinson's Disease
2019
57
50
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
Npj Parkinson's Disease
2021
56
site/software ©
exaly
; All materials licenced under
CC by-SA
.